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Abstract
Background: The expression of recombinant proteins in eukaryotic cells requires the fusion of
the coding region to a promoter functional in the eukaryotic cell line. Viral promoters are very
often used for this purpose. The preceding cloning procedures are usually performed in Escherichia
coli and it is therefore of interest if the foreign promoter results in an expression of the gene in
bacteria. In the case molecules toxic for humans are to be expressed, this knowledge is
indispensable for the specification of safety measures.
Results: We selected five frequently used viral promoters and quantified their activity in E. coli with
a reporter system. Only the promoter from the thymidine kinase gene from HSV1 showed no
activity, while the polyhedrin promoter from baculovirus, the early immediate CMV promoter, the
early SV40 promoter and the 5' LTR promoter from HIV-1 directed gene expression in E. coli. The
determination of transcription start sites in the immediate early CMV promoter and the polyhedrin
promoter confirmed the existence of bacterial -10 and -35 consensus sequences. The importance
of this heterologous gene expression for safety considerations was further supported by analysing
fusions between the aforementioned promoters and a promoter-less cytotoxin gene.
Conclusion: According to our results a high percentage of viral promoters have the ability of
initiating gene expression in E. coli. The degree of such heterologous gene expression can be
sufficient for the expression of toxin genes and must therefore be considered when defining safety
measures for the handling of corresponding genetically modified organisms.
Background
The production of recombinant proteins in eukaryotic
cells requires the fusion of the target genes to promoter
sequences functional in the eukaryotic cells and exhibit-
ing the desired expression pattern. The molecular cloning
procedures necessary for the construction of these fusions
are usually performed in bacteria, mostly in Escherichia
coli K12. A heterologous expression of powerful toxins
like for example botulinum toxin, tetanus toxin or diph-
theria toxin may pose a risk for the persons carrying out
the experiments. A careful risk analysis considering an
exposition to the toxin produced in the eukaryotic cells as
Published: 20 June 2005
BMC Biotechnology 2005, 5:19 doi:10.1186/1472-6750-5-19
Received: 01 February 2005
Accepted: 20 June 2005
This article is available from: http://www.biomedcentral.com/1472-6750/5/19
© 2005 Lewin et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9
(page number not for citation purposes)
BMC Biotechnology 2005, 5:19 http://www.biomedcentral.com/1472-6750/5/19well as a potential danger originating from toxin produc-
tion by the recombinant E. coli has therefore to be carried
out.
Since the nucleic acid sequences characterising eukaryotic-
type and bacterial promoters are different, it is usually
regarded improbable that promoter sequences functional
in eukaryotic cells are able to direct a considerable tran-
scription initiation in bacteria [1,2].
There are numerous differences between the transcription
machinery of eukaryotes and eubacteria represented by
different structures of promoters and the complexity of
RNA polymerases and transcription factors [3-6]. On the
other hand, the RNA polymerases are evolutionary con-
served and belong to a protein family termed "multisubu-
nit RNAP family" [4,7,8]. The subunits of the eubacterial
RNA polymerase all have counterparts in the subunits of
the RNA polymerase from Archaea and the three RNA
polymerases from eukaryotes [4,8-11]. There is also an
obvious similarity between the TATA box from eukaryotes
and Archaea to the -10 consensus sequence from eubacte-
rial promoters.
This discrepancy reflected by differences versus similari-
ties of the transcription machinery of organisms belong-
ing to different kingdoms motivated us to analyse the
capacity of promoter sequences to direct gene expression
in foreign hosts. In previous studies we have shown that a
high percentage of eukaryotic-type promoters specific for
plants can direct gene expression in eubacteria. By testing
promoter activity of ten plant-specific promoters in five
eubacterial species we could show that in 50 % of the
tested combinations the promoter sequences could be
used in the bacterial host [12,13]. In a subsequent study
we demonstrated that not only eukaryotic promoter
sequences but any type of eukaryotic DNA has a high
probability to initiate transcription after transfer into bac-
teria. This was shown by transfer of random DNA frag-
ments from the yeast Saccharomyces cerevisiae into E. coli
K12 and detection of initiation of significant gene expres-
sion in about 80 % of the transformed E. coli [14].
In this study we addressed the question if heterologous
gene expression in E. coli by viral promoters has to be con-
sidered when specifying safety measures for correspond-
ent experiments. We selected five frequently used viral
promoter sequences: (i) the polyhedrin promoter from
baculovirus (P PH), (ii) the enhancer and immediate early
promoter from CMV (P CMV), (iii) the early promoter
from SV40 (P SV40), (iv) the thymidine kinase promoter
from HSV1 (P TK), and (v) the 5'LTR promoter from HIV
(P LTR). The heterologous gene expression of these pro-
moters in E. coli K12 was tested using the luxAB genes
from Vibrio harveyi as reporter system. Two of the promot-
ers (P PH and P CMV) were analysed in more detail to
determine the transcription start sites in E. coli. By addi-
tionally fusing these two promoters to a gene encoding a
cytotoxin (hemolysin gene vlly from Vibrio vulnificus) the
relevance of the heterologous gene expression by viral
promoters for safety considerations was further
supported.
Results and discussion
Lux gene expression in E. coli directed by viral promoters
To investigate whether viral promoters can initiate gene
expression in bacteria, we constructed fusions between
various viral promoters and the promoter-less luxAB genes
from V. harveyi, transformed the fusions into E. coli K12
and measured the luminescence of the transformants. The
viral promoters analysed were the polyhedrin promoter
from baculovirus (P PH), the enhancer and immediate
early promoter from CMV (P CMV), the early promoter
from SV40 (P SV40), the thymidine kinase promoter from
HSV1 (P TK), and the 5'LTR promoter from HIV (P LTR).
As positive controls gene expression levels caused by
homologous bacterial promoters in E. coli were deter-
mined by fusing the promoter from the nptIII gene (P
NPTIII) and the promoter from the TEM-1 β-lactamase
gene (P BLA) to the luxAB genes. The vector pKKlux with-
out any promoter sequence was included as negative con-
trol. The results of the luminescence measurements are
shown in Fig. 1A. The vector pKKlux generated a back-
ground luminescence (212 RLU/10 s), which was identi-
cal to the luminescence caused by the P TK construct (210
RLU/10 S). The P PH (824 RLU/10 s) initiated a weak
gene expression in E. coli, while the P LTR (2382 RLU/10
s) caused a luminescence 10 times above background. The
P CMV (11981 RLU/10 s) and the P SV40 (12301 RLU/10
s) initiated a strong gene expression in E. coli, which was
comparable to the gene expression of the bacterial P BLA
(16350 RLU/10s). The bacterial P NPTIII caused the high-
est luminescence values with 36011 RLU/10 s. In sum-
mary, four of the five viral promoters tested generated a
luminescence at least four times above background (P PH,
P CMV, P SV40, P LTR). The luminescence caused by the
P CMV and P SV40 was even similar to the luminescence
caused by the bacterial P BLA supporting the relevance of
the heterologous gene expression with respect to the phe-
notypic expression of transferred traits.
Confirmation that our reporter assay reliably reflects the
strength of the tested promoters was achieved by perform-
ing quantitative RT-PCR assays using primers and probes
specific for the luxB gene (Fig. 1B).
Mapping of DNA sequences in viral promoters serving as 
transcription start sites in E. coli
We chose two different approaches to determine the loca-
tion of DNA sequences in the viral promoters which mayPage 2 of 9
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Gene expression caused by viral promoters in E. coli. Luminescence (Panel A) and amount of lux AB mRNA transcripts 
determined by Real-time RT-PCR (Panel B) of cultures of E. coli containing fusions between the luxAB genes in the vector 
pKKlux and the viral promoters P TK (thymidine kinase promoter from HSV1), P PH (polyhedrin promoter from baculovirus), 
P CMV (immediate early promoter from CMV), P SV40 (early promoter from SV40) and P LTR (5' LTR promoter from HIV1) 
or the bacterial promoters P BLA (promoter from the TEM-1 β-lactamase gene) and P NPTIII (promoter from the neomycin-
phosphotransferase III gene). E. coli containing pKKlux was included in both experiments as negative control. The luminescence 
(Panel A) was measured in triplicate and the columns represent the average of the three measurements with the standard devi-
ation. The lux AB mRNA (Panel B) was measured in duplicate and the columns represent the average of the two 
measurements.Page 3 of 9
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polymerase from E. coli.
The first approach consisted in a statistical analysis of the
nucleotide sequences of the promoters with a neural net-
work promoter prediction program [15]. The number of
predicted prokaryotic promoters in the five sequences
analysed varied from zero to six. Surprisingly, the pro-
moter prediction program identified no potential pro-
moter sequence in the P SV40, which was the promoter
causing the strongest luminescence in our reporter assays
(Fig. 1A). The construct with the P CMV, which was
almost as strong as the construct with the P SV40 in the
luminescence assay, was shown by statistical analysis to
have six potential start sites. In each of the remaining
three promoter sequences (P PH, P TK, P LTR), the pro-
moter prediction program predicted one potential start
site. Interestingly, a potential promoter was also identified
in the P TK sequence, although the P TK luxAB fusion
pointed out to be negative in the luminescence assay.
In summary, it can be concluded that a prediction of the
gene expression activity of a DNA sequence solely on the
basis of a statistical analysis of the sequence is not reliable,
and that only an experimental approach using a reporter
system can provide this information. This result is in good
agreement with the outcome of our previous studies [12-
14] on the functionality of plant promoters in bacteria
and on the promoter activity of yeast DNA in E. coli. There
we also demonstrated that it was not possible to reliably
predict the occurrence of a bacterial promoter in a DNA
sequence by statistical analysis.
Our second approach consisted in the experimental deter-
mination of transcription start sites by the 5' RACE-
method and sequencing of the 5' RACE products. For this
purpose, we selected two viral promoters which had both
been shown to direct gene expression according to the
results of the luminescence measurements. The construct
with the P CMV belonged to the viral promoters initiating
a very strong heterologous gene expression, while the P
PH caused a weak heterologous gene expression in E. coli.
Constructs containing the bacterial promotersP BLA and P
NPIII were included into the experiments as positive
controls.
The results summarised in Fig. 2 show the transcription
start sites and the location of the putative -10 and -35-
regions. The transcription start sites determined in the P
BLA and P NPTIII promoter regions by the 5' RACE
method were identical with the start sites described by
other authors [16,17] confirming our experimental
approach.
We could identify specific start sites in the two tested con-
structs containing the viral promoters P PH and P CMV
confirming that the luminescence resulted from specific
transcription initiation events. One start site was identi-
fied in the P PH, whereas two start sites were found in the
P CMV (Fig. 2). In the upstream region of all transcription
start sites we found at a distance of 5 to 7 bp a region with
similarity to the -10 (TATAAT) consensus sequence which
was separated by 14 to 18 bp from a region with similarity
to the -35 (TTGACA) consensus sequence.
It was very astonishing, that none of the transcription start
sites within the viral promoters determined by the 5'
RACE method corresponded to the transcription initia-
tion sites predicted by the promoter prediction pro-
gramme (data not shown). The difficulties encountered in
the efforts to predict promoter activities in bacteria by sta-
tistical analysis can at least in part be explained by the
importance of the nucleotide sequences surrounding the -
10 and -35 regions which determine the physical-chemi-
cal and structural characteristics of the DNA and the pro-
moter strength [18,19]. Jacquet and Reiss [18], for
example, analysed the influence of the context of the -10
and -35 regions on transcription efficiencies and found
that transcription efficiencies varied by a factor of ten
depending on the sequences surrounding the consensus
sequences. Progress in bacterial promoter prediction has
been made using neural network programs like the one
we have employed for our statistical analysis. Demeler
and Zhou [20] reported a prediction accuracy of 98.4 %
using a neural network for the prediction of E. coli pro-
moters. Further problems of promoter predictions consist
in the existence of different sigma factors binding to dif-
ferent recognition sequences and in the variation between
the consensus sequences of different bacterial species.
Expression of the hemolysin gene vlly from V. vulnificus in 
E. coli directed by viral promoters
As heterologous gene expression was observed using luci-
ferase as reporter system, we were interested, if the pro-
moter activity of the viral promoter sequences in E. coli
was sufficiently strong to significantly express virulence
factors. This would be of importance for risk assessments
of corresponding genetically modified organisms. For
instance it has been shown that the transfer of the inv
locus necessary for the invasion of Yersinia pseudotubercu-
losis into host cells enabled a non-invasive strain of E. coli
to penetrate cultured cells [21]. Similar observations have
been made with the invasion locus of Mycobacterium
avium. After transfer of this locus into non-invasive E. coli
and Mycobacterium smegmatis the recipients could invade
epithelial cells [22]. A worst case scenario would be the
heterologous expression of a toxin able to operate without
being dependent on other virulence factors. Many hemo-
lysin genes fulfil this condition. The phenotypic effect ofPage 4 of 9
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lysin genes are prevalent in many pathogenic bacteria. We
selected the vlly gene from V. vulnificus as reporter gene
[23]. An advantage of vlly for our purposes is its small size
(1071 bp) facilitating the amplification and cloning pro-
cedures. Furthermore, a 1.3 kb fragment of V. vulnificus
DNA carrying vlly has been shown to confer a hemolytic
phenotype onto E. coli [23].
We inserted the promoter-less vlly (including the Shine-
Dalgarno-Sequence) downstream from the viral promot-
ers P PH and P CMV present in the pKKlux constructs and
transformed the promoter-vlly fusions into E. coli K12. As
negative control, vlly was inserted into pKKlux without
any promoter sequences.
We first monitored the vlly expression by plating the trans-
formants onto blood agar plates and observing hemolysis
zones around the colonies. E. coli containing P PH as well
as E. coli containing P CMV were hemolytic (Fig. 3B,C).
However, a quantification to what extent a lysis of eryth-
rocytes had occurred, was not possible with this method.
We therefore also measured release of haemoglobin from
lysed erythrocytes in a liquid hemolysis assay. Since Vlly
had been shown before to be located in the periplasma
and cytoplasma of recombinant E. coli [23], our assay
involved sonication of the E. coli cells to liberate periplas-
mic and cytoplasmic Vlly. The outcome of a typical hemo-
lysis assay is shown in Fig. 3D. Both viral promoters
initiated an expression of vlly. In accordance with the
luminescence assays, the P CMV directed a very strong vlly
expression resulting in lysis of almost half the erythrocytes
present in the assay, while the P PH was much weaker
causing a lysis of about 20% of erythrocytes.
Conclusion
We showed that four (polyhedrin gene promoter from
baculovirus, immediate early promoter from CMV, early
promoter from SV40 and LTR promoter from HIV 1) out
Identification of transcription start sitesFigure 2
Identification of transcription start sites. Transcription start sites were identified by the 5' RACE method in E. coli con-
taining pKKlux derivatives with fusions between the promoterless luxAB genes and the promoter from the nptIII gene (P 
NPTIII), the promoter from the TEM-1 gene (P BLA), the polyhedrin promoter (P PH) and the immediate early CMV promoter 
(P CMV). The sequences shown cover the transcription initiation sites identified in E. coli (indicated by arrows) and their 
upstream regions. The putative -10 and -35 regions are underlined. Two transcription start sites [a), b)] were identified in the 
P CMV.Page 5 of 9
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required by the bacterial RNA polymerase to initiate tran-
scription. Two promoters (P CMV and P SV40) were as
strong as the promoter from the bacterial TEM1-β-lacta-
mase gene. The determination of the transcription start
sites in selected viral promoters confirmed the presence of
Expression of hemolysin genes in E. coli directed by viral promotersFigure 3
Expression of hemolysin genes in E. coli directed by viral promoters. Hemolysis of sheep blood erythrocytes by E. coli 
DH5α containing the vlly coding sequence without promoter (panels A and D), with the promoter from the polyhedrin gene (P 
PH: panels B and D) or with the immediate early promoter from CMV (P CMV: panels C and D). Panels A to C show the 
hemolysis in blood agar plates visible as cleared zones around the colonies. Panel D indicates the percentage of erythrocytes 
lysed in a liquid blood assay. The columns show the average of two measurements.Page 6 of 9
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promoter consensus sequences. Two promoters (P CMV
and P PH) were shown to be able to direct expression of a
bacterial cytotoxin, which illustrated the relevance of this
type of heterologous gene expression for the specification
of safety measures for the handling of genetically modi-
fied organisms. A strong expression of a foreign gene by a
heterologous promoter must either be taken into consid-
eration when defining safety measures or if necessary, it
must be excluded by performing appropriate experiments.
If there is the need for exclusion of a heterologous gene
expression, care should be taken in choosing convenient
promoter sequences. Alternatively, site-directed mutagen-
esis can be employed to design promoter sequences
according to the experimental requirements. By exchang-
ing nucleotides, which are required for binding of the bac-
terial RNA-polymerase, but which are of no or little
importance for the transcription initiation in the final
eukaryotic recipient, it is possible to minimise the heterol-
ogous gene expression while maintaining the desired
characteristics of the promoter with regard to its function
in eukaryotic cells or tissues [13]. Finally, the generation
of a functional gene product not only depends on the
presence of functional promoter sequences but can be
also influenced by factors like the presence or absence of
introns, the codon usage, post-translational modifications
or the necessity of protein secretion.
Methods
Bacteria and growth conditions
Escherichia coli K12 strain DH5α [24] and Vibrio vulnificus
strain CH1603 (O:8, isolated from the Baltic Sea, Ger-
many) were grown at 37°C overnight in LB medium [25].
Measurement of luminescence
The measurement of luciferase activity was performed as
described before [12]. Bacterial cultures were grown at
28°C up to an optical density (λ = 600 nm) of 1.0 to 1.3
and diluted to contain 106 cells per ml. After transfer of
100 µl (microliter) of the diluted cultures into microtiter
plates, 50 µl of 2 % decanal in 50 mM sodium phosphate
buffer, pH 7.0, were added and the luminescence (RLU:
relative light units) was measured in triplicate at 28°C for
10 s in the Microlumat LB96P from EG&G Berthold (Bad
Wildbad, Germany).
Detection of hemolysis
To detect hemolysis on blood agar plates, a broth culture
of the bacteria was either streaked or plated onto entero-
hemolysin agar plates (Oxoid, Wesel, Germany) and incu-
bated at 37°C. The plates were evaluated visually after 40
hours.
A quantification of the hemolytic activity of the bacteria
was achieved using defibrinated sheep blood (Oxoid,
Wesel, Germany) that was washed three times with PBS
buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2
mM KH2PO4, pH 7.4). The bacteria were incubated at
37°C up to an optical densitiy (λ = 588 nm) of 1.3. To lib-
erate intracellular hemolysin, the cells were disrupted
using ultrasound for 1 min at 50 watt in the Branson Son-
ifier 450 (Branson Ultrasonics Corporation, Danbury, CT,
USA). The disrupted cell lysate was at once placed on ice
and centrifuged for 10 min at 9300 g. 970 µl of the super-
natant were spiked with 20 µl washed blood and 10 µl 1
M CaCl2 and incubated at 37°C for 45 min. Every 5 min
the suspension was carefully mixed. The mixture was then
centrifuged at 1500 g for 10 min and the haemoglobin in
the supernatant was quantified by measuring the OD at
540 nm. The value for complete lysis of erythrocytes
(OD>2) was obtained by using distilled water instead of
culture supernatant. All cultures were measured in
duplicate.
Molecular biology techniques
Common molecular biology techniques (DNA isolation,
restriction digestion, ligation, electrophoresis) were car-
ried out according to standard protocols [25] or according
to the recommendations of the manufacturers of kits and
enzymes. Sequencing reactions were performed by using
the Prism Big Dye™ FS Terminator Cycle Sequencing
Ready Reaction Kit from PE Applied Biosystems, Weiter-
sheim, Germany. Transformation of E. coli was performed
according to the method of Hanahan [24].
Construction of recombinant plasmids
Viral promoters as well as bacterial promoters were
inserted into the vector pKKlux [12]. pKKlux (7.7 kb) is a
derivative of the promoter probe vector pKK232-8 [26],
which carries a promoter-less cat (chloramphenicol-
acetyltransferase) gene in front of the multiple cloning
site. Read-through into the cat gene is prevented by the
transcription terminator of the rrnb gene from E. coli.
pKK232-8 contains a beta-lactamase gene to allow selec-
tion by adding ampicillin (100 µg/ml) into the medium.
pKKlux was generated by inserting in front of the cat gene
the promoterless luciferase genes luxAB from Vibrio harveyi
present in plasmid pUT/mini-Tn5 luxAB [27], allowing
the determination of promoter activities by measuring
luminescence.
The promoter fragments were amplified by PCR using
primers provided with restriction sites for the restriction
enzymes SmaI and XbaI allowing ligation into the SmaI /
XbaI sites of pKKlux. This cloning strategy guaranteed cor-
rect orientation of the promoters upstream from the pro-
moter-less luxAB genes. Only the PTK, which contains a
SmaI site, was not digested with SmaI prior to ligation of
the PCR fragment into pKKlux.Page 7 of 9
(page number not for citation purposes)
BMC Biotechnology 2005, 5:19 http://www.biomedcentral.com/1472-6750/5/19Table 1 describes the generated promoter fragments and
the templates and primers used for their amplification.
For cloning of the hemolysin gene vlly from V. vulnificus
[23,28], a 1118 bp fragment carrying a promoterless vlly
was amplified using the primers vlly-S (GGTCTAGAG-
CAGTCTAAAAGGAGAAAGTCATGGTGG) and vlly-AS
(GGTCTAGACCCGATGAGGAAAGGTGATCC). The prim-
ers had been provided with XbaI restriction sites allowing
insertion of vlly in the XbaI site of the pKK232-8-deriva-
tives containing the promoters described in Table 1.
Correct orientation of vlly downstream of the analysed
promoters was confirmed by sequencing.
Quantification of lux mRNA
Bacterial cultures were grown over night in LB medium at
28°C. 200 µl of these cultures were inoculated into 5 ml
of LB medium and grown for 4 to 6 hours to an optical
density (λ = 600 nm) of 1.0. Aliquots of these cultures
were taken for RNA isolation. RNA was isolated with the
SV Total RNA Isolation System Kit from Promega, Madi-
son, USA, which includes a DNase digestion step. The RT-
PCR was performed with the Titan™ One Tube RT-PCR
System from Boehringer Mannheim (Indianapolis, Ind.,
USA) in the ABI Prism 7700 Sequence Detection system
(Applied BioSystems Division, Perkin Elmer, Foster City,
Calif., USA). The primer pair used for the quantitative RT-
PCR [Lux2270F (CCGTTAACCCACACGCGT) and
Lux2329R (TGCTCGTCGCATTCACAAA)] amplified a 60
bp fragment from the luxB gene. The dually labelled detec-
tor probe hybridising within the sequence between these
primers had the sequence (FAM)-CACTGAAGGCGGTC-
CTGCGCA-(TAMRA). The RT-PCR was performed with
0.1 µg RNA in 50 µl reaction mix according to the recom-
mendations of the manufacturer (with RT-reaction buffer,
1.5 mM MgCl2, 0.2 mM of each dNTP, 1 µM downstream
primer, 1 µM upstream primer, 5 mM DTT, 5 U RNase
inhibitor, 1 µl of enzyme mix containing AMV, Taq DNA
polymerase and Pwo DNA polymerase). The quantitative
TaqMan RT-PCR furthermore required addition of 180
nM dually labelled probe and 1 µM ROX (6-Carboxy-X-
rhodamin) as passive reference dye. The reverse transcrip-
tion was carried out at 50°C for 30 min and terminated by
heating at 95°C for 10 min. Amplification was carried out
by running 35 cycles with 30 sec at 95°C and 1 min at
60°C. Samples were measured in duplicate. The amount
of the lux mRNA was determined by the help of a standard
established with known amounts (0.073 pg to 730 pg) of
the plasmid pKKlux.
Mapping of transcription start sites with the 5' RACE 
method
Total RNA from broth cultures was isolated with the SV
Total RNA Isolation System Kit from Promega, Madison,
USA. The 5' ends of the lux transcripts were mapped with
the 5' RACE (Rapid Amplification of cDNA Ends) System
Kit from Life Technologies, Inc., Rockville, USA. 1 to 5 µg
of total RNA was used to synthesise cDNA from the 5' end
of the lux mRNA with the gene-specific primer GSP1/luxA
(CAACATAAGGATTCCC). The reaction was performed
with the SuperScript II RT at 42°C for 50 min. A
homopolymeric C-tail was added to the cDNA with the
terminal deoxynucleotidyl transferase. The RACE prod-
ucts were synthesised using the abridged anchor primer
Table 1: Promoters analysed in this study. The promoters (column 1 and 4) were amplified by PCR using the template DNA (column 
2) and the primers (column 3) listed in the table.
Promoter fragment Template DNAa Primer sequenceb Size of 
promoter-
fragment
P PH: Polyhedrin promoter from 
baculovirus
pBacPAK8 [29] PH-1: GCCCGGGCCATCTCGCAAATAAATAAG
PH-2: GTCTAGACAGGGATCCGTATTTATAGG
78 bp
P CMV: Enhancer and immediate 
early promoter from CMV
pRL-CMV [30] CMV-1: GCCCGGGGATCTTCAATATTGGCCATTAGCC
CMV-2: GTCTAGACACTGACTGCGTTAGCAATTTAAC
802 bp
P SV40: Early promoter from SV40 pGL3 [31] SV40-1: GCCCGGGCTAGCCCGGGCTCGAGATCTG
SV40-2: GTCTAGATTTGCAAAAGCCTAGGCCTCC
223 bp
P TK Thymidine kinase promoter 
from HSV1
pRL-TK [32] TK-1: GCCCGGGATCTAAATGAGTCTTCGGACCTCGC
TK-2: TCTAGACGAGACTGTTGTGTCAGAAGAATCAAGC
788 bp
P LTR HIV-1 subtype D 5'LTR 
promoter
isolate 92UG021 LTR-1: GGCCCGGGATTAGATATCCACTGACCTTTGGATGGTGC
LTR-2: GGTCTAGATTAAGCAGTGGGTTCCCTAGCTAGCC
412 bp
P NPTIII: nptIII promoter pBin19 [33, 34] NPTIII-S: GCGCCCGGGCATAATTGTGGTTTCAAAATCGGC
NPTIII-AS: GGGTCTAGATTATTATTTCCTTCCTCTTTTC
193 bp
P BLA: TEM-1 promoter pKK232-8 [26, 35] Amp-S: GCGCCCGGGCGTCAGGTGGCACTTTTCG
Amp-AS: GGGTCTAGAACTCTTCCTTTTTCAATATTATTG
134 bp
apBacPAK8 was from Clontech (Palo Alto, CA, USA), pRL-CMV, pGL3 and pRL-TK were from Promega (Madison, WI, USA). The 5'LTR promoter 
sequence was kindly provided by S. Somogyi.
bRestriction sites added to the primers for cloning purposes are italicised.Page 8 of 9
(page number not for citation purposes)
BMC Biotechnology 2005, 5:19 http://www.biomedcentral.com/1472-6750/5/19GGCCACGCGTCGACTATACGGGIIGGGIIGGGIIG and
the gene-specific primer GSP2/luxA (GCGTACTAGT-
CAGTGAAGTGGTGCTCTAGCAACC). The PCR program
was run with 35 cycles composed of a denaturation step
of 1 min at 94°C, an annealing step of 30 sec at 65°C and
an elongation step of 2 min at 68°C. The RACE products
were directly sequenced to identify transcription start
sites.
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